Different regulatory pathways are involved in the proliferative inhibition of two types of leukemia cell lines induced by paclitaxel

Oncology Reports

Volumn 30, Issue 4, 2013, Pages 1853-1859

  Xia, Rui Long ^a   Lu, Yan ^a   Zhu, Li Na ^a   Zhang, Shi Fu ^a   Zhao, Fu Kun ^a   Fu, Cai Yun ^a  

^a ZHEJIANG SCI TECH UNIVERSITY   (China)

Author keywords

Apoptosis; Leukemia cells; Necrosis; Paclitaxel

Indexed keywords

PACLITAXEL;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CELL PROLIFERATION; CELL STRAIN K562; CELL STRAIN MEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; LEUKEMIA; M PHASE CELL CYCLE CHECKPOINTS; PACLITAXEL;

EID: 84882683847     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2624     Document Type: Article

References (29)

1. Burris HA III: Docetaxel (Taxotere) plus trastuzumab (Herceptin) in breast cancer. Semin Oncol 28: 38-44, 2001.
2. Belani C and Lynch T: Docetaxel (Taxotere) in combination with platinums in patients with non-small cell lung cancer: trial data and implications for clinical management. Semin Oncol 28: 10-14, 2001.
3. Kaye S, Piccart M, Aapro M, Francis P and Kavanagh J: Phase II trials of docetaxel (taxotere®) in advanced ovarian cancer - an updated overview. Eur J Cancer 33: 2167-2170, 1997.
4. Horwitz S: Taxol (paclitaxel): mechanisms of action. Ann Oncol 5: S3-S6, 1994.
5. Monzó M, Rosell R, Sánchez JJ, Lee JS, O'Brate A, González-Larriba JL, Alberola V, Lorenzo JC, Núñez L, Ro JY and Martín C: Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations. J Clin Oncol 17: 1786-1793, 1999.
6. Giannakakou P, Sackett DL, Kang YK, Zhan Z, Buters JT, Fojo T and Poruchynsky MS: Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization. J Biol Chem 272: 17118-17125, 1997.
7. Ranganathan S, Benetatos C, Colarusso P, Dexter D and Hudes G: Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells. Br J Cancer 77: 562-566, 1998.
8. Wilson L, Bamburg J, Mizel S, Grisham L and Creswell K: Interaction of drugs with microtubule proteins. Fed Proc 33: 158-166, 1974.
9. Bhalla K, Ibrado A, Tourkina E, Tang C, Mahoney M and Huang Y: Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7: 563-568, 1993.
10. Havrilesky LJ, Elbendary A, Hurteau JA, Whitaker RS, Rodriguez GC and Berchuck AW: Chemotherapy-induced apoptosis in epithelial ovarian cancers. Obstet Gynecol 85: 1007-1010, 1995.
11. Chang YF, Li LL, Wu CW, Liu TY, Lui WY, P'eng FK and Chi CW: Paclitaxel-induced apoptosis in human gastric carcinoma cell lines. Cancer 77: 14-18, 1998.
12. Yen WC, Wientjes MG and Au JLS: Differential effect of taxol in rat primary and metastatic prostate tumors: site-dependent pharmacodynamics. Pharm Res 13: 1305-1312, 1996.
13. Fallo F, Pilon C, Barzon L, Pistorello M, Pagotto U, Altavilla G, Boscaro M and Sonino N: Effects of taxol on the human NCI-H295 adrenocortical carcinoma cell line. Endocr Res 22: 709-715, 1996.
14. Terzis AJ, Thorsen F, Heese O, Visted T, Bjerkvig R, Dahl O, Arnold H and Gundersen G: Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. Br J Cancer 75: 1744-1752, 1997.
15. Rowinsky EK: The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 48: 353-374, 1997.
16. Al-Alami O, Sammons J, Martin J and Hassan H: Divergent effect of taxol on proliferation, apoptosis and nitric oxide production in MHH225 CD34 positive and U937 CD34 negative human leukaemia cells. Leuk Res 22: 939-945, 1998.
17. Richards W, Song MK, Krutzsch H, Evarts R, Marsden E and Thorgeirsson S: Measurement of cell proliferation in microculture using Hoechst 33342 for the rapid semiautomated microfluorimetric determination of chromatin DNA. Exp Cell Res 159: 235-246, 1985.
18. Shi Y, Wei Y, Qu S, Wang Y, Li Y and Li R: Arsenic induces apoptosis of human umbilical vein endothelial cells through mitochondrial pathways. Cardiovasc Toxicol 10: 153-160, 2010.
19. Gangemi RM, Tiso M, Marchetti C, Severi AB and Fabbi M: Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother Pharmacol 36: 385-392, 1995.
20. Haldar S, Basu A and Croce CM: Bcl2 is the guardian of microtubule integrity. Cancer Res 57: 229-233, 1997.
21. Gangemi RM, Santamaria B, Bargellesi A, Cosulich E and Fabbi M: Late apoptotic effects of taxanes on K562 erythroleukemia cells: apoptosis is delayed upstream of caspase-3 activation. Int J Cancer 85: 527-533, 2000.
22. Seiter K, Feldman EJ, Traganos F, Li X, Halicka HD, Darzynkiewicz Z, Lederman CA, Romero MB and Ahmed T: Evaluation of in vivo induction of apoptosis in patients with acute leukemia treated on a phase I study of paclitaxel. Leukemia 9: 1961-1966, 1995.
23. Consolini R, Pui C-H, Behm FG, Raimondi SC and Campana D: In vitro cytotoxicity of docetaxel in childhood acute leukemias. J Clin Oncol 16: 907-913, 1998.
24. Ney PA and D'Andrea AD: Friend erythroleukemia revisited. Blood 96: 3675-3680, 2000.
25. Friend C: Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J Exp Med 105: 307-318, 1957.
26. Yusuf R, Duan Z, Lamendola D, Penson R and Seiden M: Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation. Curr Cancer Drug Targets 3: 1-19, 2003.
27. Wang TH, Wang HS and Soong YK: Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 88: 2619-2628, 2000.
28. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T and Traganos F: Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27: 1-20, 1997.
29. Majno G and Joris I: Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146: 3-15, 1995.